Janet Vergis has more than 25 years’ experience in the healthcare industry with a strong track record with growing businesses. She currently serves as an Executive Advisor to private equity firms and was most recently Chief Executive Officer of OraPharma, Inc. where she led the successful turnaround and subsequent sale of the company. Prior to these roles, Ms. Vergis managed a $6 billion portfolio at Johnson & Johnson as President of Janssen Pharmaceutica, McNeil Pediatrics, and Ortho-McNeil Neurologics. Vergis currently serves on the Board of Directors for Church and Dwight Co., Inc. and Impax Laboratories, Inc., is Chairman of The Biotech Advisory Board and a Member of The Dean’s Advisory Counsel for The Eberly College of Science at The Pennsylvania State University.
Ms. Vergis earned a B.S. degree in Biology and an M.S. degree in Physiology from Penn State.